Copyright
©The Author(s) 2024.
World J Hepatol. Jan 27, 2024; 16(1): 33-40
Published online Jan 27, 2024. doi: 10.4254/wjh.v16.i1.33
Published online Jan 27, 2024. doi: 10.4254/wjh.v16.i1.33
Figure 1 Algorithm proposed by the European Association for the Study of Liver targets patients at high risk of metabolic dysfunction-associated steatotic liver disease seen in primary health care.
ALP: Alkaline phosphatase; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; FIB-4: Fibrosis-4; GGT: Gamma-glutamyl transferase; HBV: hepatitis B virus; HCV: Hepatitis C virus.
- Citation: Vargas M, Cardoso Toniasso SC, Riedel PG, Baldin CP, dos Reis FL, Pereira RM, Brum MCB, Joveleviths D, Alvares-da-Silva MR. Metabolic disease and the liver: A review. World J Hepatol 2024; 16(1): 33-40
- URL: https://www.wjgnet.com/1948-5182/full/v16/i1/33.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i1.33